Table 4.

Percentage differences in respondents’ choice of treatment for oral candidiasis, classified according to socio-professional factors (n = 330)

Socio-professional factors	Prescribed treatment
	Topical treatment		Systemic treatment		Nystatin		Amphotericin		Miconazole		Chlorhexidine		Fluconazole		Other
	(n = 292)	P*	(n = 70)	P*	(n = 258)	P*	(n = 44)	P*	(n = 206)	P*	(n = 240)	P*	(n = 36)	P*	(n = 4)	P*
	n (%)		n (%)		n (%)		n (%)		n (%)		n (%)		n (%)		n (%)
Gender
Male (n = 206)	192 (93.2)	0.001	50 (24.3)	0.095	154 (74.8)	0.055	24 (11.7)	0.248	130 (63.1)	0.815	156 (75.7)	0.127	28 (13.6)	0.046	0 (0)	0.019
Female (n = 124)	100 (80.6)		20 (16.1)		104 (83.9)		20 (16.1)		76 (61..3)		84 (67.7)		8 (6.5)		4 (3.2)
Workplace
Private practice (n = 194)	175 (90.2)	0.293	39 (20.1)	0.586	146 (75.3)	0.138	12 (6.2)	0.001	120 (61.9)	0.818	146 (75.3)	0.258	36 (18.6)	0.001	4 (2.1)	0.146
Public practice (n = 136)	117 (86.0)		31 (22.8)		112 (82.4)		32 (23.5)		86 (63.2)		94 (69.1)		0 (0)		0 (0)
Year of first degree qualification
1991–2010 (n = 262)	242 (92.4)	0.001	60 (22.9)	0.182	214 (81.7)	0.005	36 (13.7)	0.842	175 (66.8)	0.002	207 (79)	0.001	36 (13.7)	0.001	4 (1.5)	0.585
Before 1991 (n = 68)	50 (73.5)		10 (14.7)		44 (64.7)		8 (11.8)		31 (45.6)		33 (48.5)		0 (0)		0 (0)
Country of first degree qualification
Jordan (n = 191)	171 (89.5)	0.491	52 (27.2)	0.002	155 (81.2)	0.139	16 (8.4)	0.003	132 (69.1)	0.004	155 (81.2)	0.001	32 (6.8)	0.001	4 (2.1)	0.141
Other (n = 139)	121 (87.1)		18 (12.9)		103 (74.1)		28 (20.1)		74 (53.2)		85 (61.2)		4 (2.9)		0 (0)

^*Fisher’s exact test (two-tailed).

Bold values indicate statistically significant at the 0.05 probability level (two-tailed).